2025-05-30 - Analysis Report
Okay, here's an analysis of Colgate-Palmolive (CL) based on the provided data. The report is structured to provide key numbers first, followed by interpretations and context.

## Colgate-Palmolive Co. (CL) Stock Analysis

### 1. Performance vs. S&P 500 (VOO)

*   **Ticker:** CL
*   **Company:** Colgate-Palmolive Co
*   **Description:** Colgate-Palmolive is a global consumer products company focused on the production, distribution, and sale of household, health care, personal care, and pet nutrition products.

**Key Numbers:**

*   CL Cumulative Return: 25.17%
*   VOO (S&P 500) Cumulative Return: 82.09%
*   Absolute Divergence (CL - VOO): -56.9%
*   Divergence Range (Max: 7.4%, Min: -64.8%)
*   Relative Divergence: 10.9%

**Analysis:**

Colgate-Palmolive has significantly underperformed the S&P 500 (VOO) over the observed period.  The absolute divergence highlights a large gap in cumulative returns.  The relative divergence of 10.9% indicates that CL's performance is near the lower end of its historical divergence range compared to VOO.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha   | Beta | Cap(B) |
| :----------- | :------ | :------ | :------ | :--- | :------ |
| 2015-2017  | 13.0%   | 4.8%    | -16.0%  | 0.1  | 51.2   |
| 2016-2018  | -11.0%  | 65.2%   | -29.0%  | 0.1  | 41.4   |
| 2017-2019  | 7.0%    | 65.2%   | -22.0%  | 0.2  | 49.1   |
| 2018-2020  | 18.0%   | 65.2%   | -8.0%   | 0.7  | 62.4   |
| 2019-2021  | 30.0%   | 58.6%   | -25.0%  | 1.0  | 63.7   |
| 2020-2022  | 8.0%    | 69.0%   | 1.0%    | 1.0  | 60.2   |
| 2021-2023  | 8.0%    | 69.0%   | -9.0%   | 0.9  | 62.5   |
| 2022-2024  | 15.0%   | 69.0%   | -2.0%   | 0.8  | 72.8   |
| 2023-2025  | 11.0%   | 62.4%   | -18.0%  | 0.3  | 74.8   |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate varies significantly across the periods, showing inconsistent growth.
*   **MDD:** The Maximum Drawdown is quite high in some periods, indicating substantial risk and volatility.
*   **Alpha:** The consistently negative Alpha values (except for 2020-2022) suggest that CL has generally underperformed relative to its risk (Beta).
*   **Beta:** The Beta values are relatively low, indicating that CL is less sensitive to market movements than the S&P 500.
*   **Cap:** The market capitalization has generally increased over the periods.

### 2. Recent Stock Price Movement

**Key Numbers:**

*   Current Price: $92.30
*   Previous Close: $91.76
*   Change: $0.59
*   5-day Moving Average: $91.996
*   20-day Moving Average: $90.763
*   60-day Moving Average: $91.6832

**Analysis:**

The stock price has shown a slight increase ($0.59) compared to the previous close. The 5-day moving average is above the 20-day and 60-day moving averages, suggesting a short-term upward trend.  The fact that the current price is above all three moving averages further supports this short-term bullish sentiment.

### 3. Market Risk Indicators and Expected Return

**Key Numbers:**

*   Market Risk Indicator (MRI): 0.366 (Low Risk)
*   RSI: 56.21
*   PPO: 0.2986
*   Hybrid Signal: cash_0%_Buy 80% of cash (2 shares - Caution - MRI:0.37)
*   20-day Relative Divergence Change: -0.9 (negative, indicating a short-term decline)
*   Expected Return: -305.4%

**Analysis:**

*   The MRI suggests a **low-risk** environment for the stock.
*   The RSI of 56.21 indicates a slightly overbought condition, but not excessively so.
*   The PPO value suggests that the short-term moving average is slightly above the long-term moving average, indicating a slightly upward trend.
*   The Hybrid Signal recommends a cautious buy, indicating that the system is not strongly confident in the stock's near-term performance.
*   The negative change in relative divergence over the past 20 days suggests a recent decline in performance relative to the S&P 500.
*   The **extremely negative expected return (-305.4%) is a significant red flag**. It indicates that, based on the model, holding CL for a long-term (2+ years) is expected to drastically underperform the S&P 500.  This requires further investigation.

The significant increase in price with `{'price': 92.3, 'previousClose': 91.76, 'change': 0.59}` suggests a positive short-term movement. However, this must be considered in context of the negative expected return, and the recent negative trend in relative divergence.

### 4. Recent News & Significant Events

*   **[2025-05-30]** Major business developments, regulatory changes, or market events affecting Colgate-Palmolive.
*   **[2025-05-28]** Analysts discussing CL's recent performance and outlook considering industry trends and global economic factors.
*   **[2025-05-26]** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **[2025-05-29]** Market experts highlighting both risks and opportunities, advising investors to monitor news and announcements.

**Analysis:**

The news snippets point to recent volatility and ongoing analyst discussions regarding CL's performance.  The references to business developments, regulatory changes, and market events suggest potential catalysts for the stock's movement.  The advice to monitor news and announcements underscores the importance of staying informed.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출       |
| :--------- | :--- | :--------- |
| 2025-04-25 | 0.85 | 4.91 B$    |
| 2024-10-25 | 0.9  | 5.03 B$    |
| 2024-07-26 | 0.89 | 5.06 B$    |
| 2024-04-26 | 0.83 | 5.07 B$    |
| 2025-04-25 | 0.83 | 5.07 B$    |

**Analysis:**

The EPS has fluctuated slightly over the past few quarters, with a range between $0.83 and $0.9. The revenue has shown a slight declining trend over the past few quarters.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue    | Profit Margin |
| :--------- | :--------- | :-------------- |
| 2025-03-31 | \$4.91B    | 60.82%        |
| 2024-12-31 | \$4.95B    | 60.30%        |
| 2024-09-30 | \$5.03B    | 61.08%        |
| 2024-06-30 | \$5.06B    | 60.62%        |
| 2024-03-31 | \$5.07B    | 60.00%        |

**Capital and Profitability:**

| Quarter    | Equity     | ROE       |
| :--------- | :--------- | :-------- |
| 2025-03-31 | \$0.36B    | 190.08%   |
| 2024-12-31 | \$0.21B    | 348.58%   |
| 2024-09-30 | \$0.43B    | 169.43%   |
| 2024-06-30 | \$0.12B    | 594.31%   |
| 2024-03-31 | \$0.23B    | 296.96%   |

**Analysis:**

*   **Revenue:** Similar to the Earnings analysis, Revenue has been trending slightly downward.
*   **Profit Margin:** The profit margin has remained relatively stable, indicating good cost management despite the slight revenue decline.
*   **Equity:** The equity values show volatility.
*   **ROE:** The ROE (Return on Equity) is extremely high and volatile. These high ROE values should be carefully scrutinized, as they might be unsustainable or the result of specific accounting practices or one-time events. Further investigation is warranted to understand the underlying drivers of these fluctuations.

### 7. 종합 Analysis

In summary:

*   **Underperformance:** CL has significantly underperformed the S&P 500.
*   **Short-Term Positive Movement:** Recent stock price action suggests a short-term upward trend.
*   **Low Risk, Cautious Buy:** The MRI indicates low risk, but the hybrid signal suggests only a cautious buy.
*   **Negative Expected Return:** The significantly negative expected return is a major concern. This needs further investigation.
*   **Stable Profitability, Declining Revenue:** The company maintains good profit margins but is experiencing a slight decline in revenue.
*   **Volatile Equity and High ROE:** The ROE figures are unusually high and volatile, requiring further investigation.
*   **Recent News:** Recent news suggests volatility and ongoing analyst discussions, indicating potential catalysts for stock movement.

**Recommendation:**

Given the significant underperformance, the extremely negative expected return, and the need to investigate the high ROE values, a cautious approach is warranted. While the recent stock price movement is positive, the overall picture suggests potential risks. Further due diligence is required before making any investment decisions. I would particularly focus on understanding the drivers behind the negative expected return and the volatile ROE. Also, I would research the specific business developments, regulatory changes, and market events mentioned in the recent news to assess their impact on the company.
